Biggest News Aggregation in the World
📰 Akouos News

Akouos News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Akouos. Real-time updates on events, politics, business and more.

Eli Lilly Sounds Off as Early Data Show How Gene Therapy Can Restore Hearing

Eli Lilly said its experimental gene therapy restored hearing in a boy born with profound hearing loss. The results for this experimental treatment come three months after Regeneron Pharmaceuticals reported early but encouraging data for its hearing loss gene therapy.
United States Lilly Akouos Eli Lilly John Germiller Regeneron Pharmaceuticals Fennec Pharmaceuticals

Eli Lilly's $487M Akouos buyout expands its gene therapy scope to hearing loss

Eli Lilly is acquiring Akouos on the heels of the biotech receiving FDA permission to begin a clinical trial testing its gene therapy for an inherited form of hearing loss. The deal is Lilly’s second gene therapy acquisition following the 2021 buyout of Prevail Therapeutics.
United States Luk Vandenbergh Eli Lilly Regeneron Pharmaceuticals Broad Institute Of Harvard Grossbeck Gene Therapy Center

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Akouos (NASDAQ:AKUS) Upgraded at Zacks Investment Research

Akouos (NASDAQ:AKUS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes AK-OTOF, […]
United States Piper Sandler Akouos Company Profile Get Rating Akouos Inc Goldman Sachs Group Inc Zacks Investment Research

Akouos (NASDAQ:AKUS) Upgraded to "Hold" by Zacks Investment Research

Zacks Investment Research upgraded shares of Akouos (NASDAQ:AKUS – Get Rating) from a sell rating to a hold rating in a research note published on Wednesday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes […]
United States Akouos Company Profile Get Rating Wells Fargo Company Akouos Inc Crossover Management Zacks Investment Research

Akouos (NASDAQ:AKUS) Upgraded at Zacks Investment Research

Akouos (NASDAQ:AKUS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes AK-OTOF, […]
United States Morgan Stanley Akouos Inc Moors Cabot Inc Crossover Management Zacks Investment Research

Zacks Investment Research Upgrades Akouos (NASDAQ:AKUS) to "Hold"

Akouos (NASDAQ:AKUS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product candidate includes […]
United States Morgan Stanley Akouos Company Profile Get Rating Crossover Management Zacks Investment Research Blackrock Inc

Akouos (NASDAQ:AKUS) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of Akouos (NASDAQ:AKUS – Get Rating) from a hold rating to a sell rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “Akouos, Inc. is a precision genetic medicine company. It develops gene therapies to restore, improve and preserve physiologic hearing. The Company’s product […]
United States Board Of Administration Florida Retirement System Sg Americas Securities Akouos Inc Moors Cabot Inc Zacks Investment Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science